Electromed (ELMD) vs EDAP TMS S.A. (FOCL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
EDAP TMS S.A. (FOCL) has outperformed Electromed (ELMD) over the past year, gaining 93.1% versus a gain of 9.6%. Over five years, ELMD leads with a +152.0% price change compared with -30.7% for FOCL. Electromed is the larger company by market cap ($229.5 million vs $197.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | FOCL |
|---|---|---|
| Share price | $27.69 | $4.19 |
| Market cap | $229.47M | $197.84M |
| 1-day change | -0.40% | +1.58% |
| YTD return | -4.91% | +27.36% |
| 1-year return | +9.58% | +93.09% |
| 5-year return | +151.96% | -30.74% |
| P/E ratio (TTM) | 21.30 | — |
| Forward P/E | 45.39 | — |
| EPS (TTM) | $1.30 | $-1.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $47.40 | $6.40 |
| 52-week low | $23.01 | $1.75 |
| Distance from 52-week high | -41.58% | -34.53% |
| Analyst consensus | none | buy |
| Avg. price target upside | +75.15% | +110.02% |
| Average volume | 97.22K | 115.89K |
| Shares outstanding | 8.29M | 47.22M |
| Employees | 195 | 289 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FOCL has outperformed ELMD by 83.5 percentage points over the past year.
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
About EDAP TMS S.A.
FOCL stock →EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 289 employees
ELMD vs FOCL FAQ
Which is bigger, Electromed or EDAP TMS S.A.?
Electromed (ELMD) is larger, with a market capitalization of $229.47M compared with $197.84M for EDAP TMS S.A. (FOCL).
Which stock has performed better over the past year, ELMD or FOCL?
FOCL returned +93.09% over the past 12 months, compared with +9.58% for ELMD (price return, excluding dividends). Past performance does not predict future results.
Are Electromed and EDAP TMS S.A. in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.